Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 8/20 | 0.41 |
| ▸ | CA2 | P00918 | 8/20 | 0.41 |
| ▸ | CA12 | O43570 | 6/20 | 0.41 |
| ▸ | CA9 | Q16790 | 6/20 | 0.41 |
| ▸ | METAP2 | P50579 | 1/20 | 0.39 |
| ▸ | TLR2 | O60603 | 1/20 | 0.39 |
| ▸ | CA4 | P22748 | 2/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | PPARG | P37231 | 2/20 | 0.38 |
| ▸ | WDR5 | P61964 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18360484 | 0.90 | CA1 (0.43) | CA1CA2CA12CA9CA4 | |
| SCHEMBL18360511 | 0.85 | CA1 (0.49) | CA1CA2CA12CA9CA4 | |
| SCHEMBL18360444 | 0.83 | NPSR1 (0.49) | CA1CA2CA12CA9L3MBTL1 | |
| SCHEMBL18360483 | 0.82 | CA1 (0.60) | CA1CA2CA12CA9CA4 | |
| SCHEMBL18360537 | 0.82 | CA1 (0.47) | CA1CA2CA12CA9METAP2 | |
| SCHEMBL18360490 | 0.80 | PDE4A (0.47) | CA1CA2CA12CA9WDR5 | |
| SCHEMBL18360476 | 0.79 | LMNA (0.46) | CA1CA2CA12CA9CA4 | |
| SCHEMBL18360466 | 0.79 | ALDH1A1 (0.49) | CA1CA2CA12CA9 | |
| SCHEMBL18360471 | 0.78 | PDE4A (0.52) | CA1CA2CA12CA9 | |
| SCHEMBL18360523 | 0.77 | HPGD (0.48) | CA1CA2CA12CA9CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170000133-A1 | BENZOXABOROLE FUNGICIDES | SYNGENTA PARTICIPATIONS AG (SE) | 2017-01-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170000133-A1 | BENZOXABOROLE FUNGICIDES | CYP4X1, BROX, CYP1B1 | CA1 3964/4885CA2 1649/4885CA12 3115/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.